The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer

類似資料

• Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancer
  著者:: Wu, Jenn-Yu, 等
  出版事項: (2016)
• Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types
  著者:: Park, Sojung, 等
  出版事項: (2021)
• Epidermal growth factor receptor tyrosine kinase inhibitors
  著者:: Ranson, M
  出版事項: (2004)
• Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors
  著者:: Ji, Hongbin, 等
  出版事項: (2006)
• Toxicity profile of epidermal growth factor receptor tyrosine kinase inhibitors in patients with epidermal growth factor receptor gene mutation-positive lung cancer
  著者:: Takeda, Masayuki, 等
  出版事項: (2017)